Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Development of a Screening Questionnaire to Discriminate Autism Spectrum Disorder and Schizotypal Disorder, and Validation of the Danish Version of RAADS-R

NCT05213286 is registered in ClinicalTrials.gov with Glostrup University Hospital, Copenhagen as lead sponsor.

NCT NCT05213286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05213286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Development of a Screening Questionnaire to Discriminate Autism Spectrum Disorder and Schizotypal Disorder, and Validation of the Danish Version of RAADS-R
Lead sponsor
Glostrup University Hospital, Copenhagen
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2022
Completion date
August 31, 2023
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, schizotypal disorder